TTK HEALTHCARE
Quarterly Results Analysis [Sep2024]
TTK HEALTHCARE Quarterly Results
Standalone | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹198 Cr | ₹208 Cr | ₹181 Cr | ₹184 Cr | ₹186 Cr | ₹202 Cr | ₹180 Cr | ₹183 Cr |
Expenses | ₹190 Cr | ₹201 Cr | ₹169 Cr | ₹179 Cr | ₹176 Cr | ₹192 Cr | ₹165 Cr | ₹174 Cr |
Operating Income | ₹8 Cr | ₹7 Cr | ₹12 Cr | ₹5 Cr | ₹10 Cr | ₹10 Cr | ₹15 Cr | ₹8 Cr |
Other Income | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹23 Cr | ₹41 Cr | ₹24 Cr | ₹18 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr | ₹16 Cr |
Profit After Tax | ₹17 Cr | ₹32 Cr | ₹18 Cr | ₹13 Cr | ₹16 Cr | ₹16 Cr | ₹20 Cr | ₹12 Cr |
EPS | ₹12.17 | ₹22.35 | ₹12.93 | ₹9.13 | ₹11.33 | ₹11.09 | ₹14.45 | ₹8.49 |
Industry Peers & Returns | 1W | 1M | 1Y |
TTK HEALTHCARE | -4% | -10.3% | 0.9% |
SUN PHARMACEUTICAL INDUSTRIES | -1.2% | 0.9% | 41.4% |
CIPLA | -1.5% | 2.2% | 16.2% |
DR REDDYS LABORATORIES | 1.4% | 10.6% | 17.2% |
ZYDUS LIFESCIENCES | 3.5% | 3.6% | 37.4% |
DIVIS LABORATORIES | -3.7% | -1.8% | 46.1% |
MANKIND PHARMA | -3.7% | 6% | 40% |
TORRENT PHARMACEUTICALS | -2.3% | -0.8% | 41.9% |
LUPIN | -4.9% | 5.5% | 62.2% |
TTK HEALTHCARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -4.53 % |
Y-o-Y | 6.85 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹198 Cr | -4.53 | |
Jun2024 | ₹208 Cr | 14.83 | |
Mar2024 | ₹181 Cr | -1.52 | |
Dec2023 | ₹184 Cr | -1.03 | |
Sep2023 | ₹186 Cr | -8.09 | |
Jun2023 | ₹202 Cr | 12.21 | |
Mar2023 | ₹180 Cr | -1.33 | |
Dec2022 | ₹183 Cr | - |
TTK HEALTHCARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 19.13 % |
Y-o-Y | -13.71 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹8 Cr | 19.13 | |
Jun2024 | ₹7 Cr | -44.37 | |
Mar2024 | ₹12 Cr | 132.75 | |
Dec2023 | ₹5 Cr | -44.05 | |
Sep2023 | ₹10 Cr | -5.05 | |
Jun2023 | ₹10 Cr | -33.82 | |
Mar2023 | ₹15 Cr | 80.13 | |
Dec2022 | ₹8 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 25.00 % |
Y-o-Y | -19.10 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 4.15% | 25.00 | |
Jun2024 | 3.32% | -51.60 | |
Mar2024 | 6.86% | 136.55 | |
Dec2023 | 2.9% | -43.47 | |
Sep2023 | 5.13% | 3.22 | |
Jun2023 | 4.97% | -40.97 | |
Mar2023 | 8.42% | 82.65 | |
Dec2022 | 4.61% | - |
TTK HEALTHCARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -45.52 % |
Y-o-Y | 7.46 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹17 Cr | -45.52 | |
Jun2024 | ₹32 Cr | 72.81 | |
Mar2024 | ₹18 Cr | 41.70 | |
Dec2023 | ₹13 Cr | -19.44 | |
Sep2023 | ₹16 Cr | 2.16 | |
Jun2023 | ₹16 Cr | -23.26 | |
Mar2023 | ₹20 Cr | 70.23 | |
Dec2022 | ₹12 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -42.92 % |
Y-o-Y | 0.58 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 8.67 % | -42.92 | |
Jun2024 | 15.19 % | 50.55 | |
Mar2024 | 10.09 % | 43.94 | |
Dec2023 | 7.01 % | -18.68 | |
Sep2023 | 8.62 % | 11.23 | |
Jun2023 | 7.75 % | -31.66 | |
Mar2023 | 11.34 % | 72.60 | |
Dec2022 | 6.57 % | - |
TTK HEALTHCARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -45.55 % |
Y-o-Y | 7.41 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹12.17 | -45.55 | |
Jun2024 | ₹22.35 | 72.85 | |
Mar2024 | ₹12.93 | 41.62 | |
Dec2023 | ₹9.13 | -19.42 | |
Sep2023 | ₹11.33 | 2.16 | |
Jun2023 | ₹11.09 | -23.25 | |
Mar2023 | ₹14.45 | 70.20 | |
Dec2022 | ₹8.49 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD